SolvGen Inc. This case discusses the company Direct Drugs Inc. and their plans to acquire SolvGen Inc. SolvGen Inc. has two material agreements with Careway Pharma Inc. One of the case requirements asks what the deliverables for the arrangement described in the case study were. These being the research and development agreement and a license and distribution agreement. The next requirement asked when the milestone payments received to date by SolvGen were to be recognized as revenue. The nonrefundable milestones include an exclusive negotiation payment of $1 million dollars paid on December 1, 2009, contract signing payment of $2 million paid on January 1, 2010, a commercial
SolvGen Inc. This case discusses the company Direct Drugs Inc. and their plans to acquire SolvGen Inc. SolvGen Inc. has two material agreements with Careway Pharma Inc. One of the case requirements asks what the deliverables for the arrangement described in the case study were. These being the research and development agreement and a license and distribution agreement. The next requirement asked when the milestone payments received to date by SolvGen were to be recognized as revenue. The nonrefundable milestones include an exclusive negotiation payment of $1 million dollars paid on December 1, 2009, contract signing payment of $2 million paid on January 1, 2010, a commercial